Avenue Therapeutics, INC. (ATXI) — DEF 14A Filings

All DEF 14A filings from Avenue Therapeutics, INC.. Browse 2 Proxy Statement reports with AI-powered summaries and risk analysis.

DEF 14A Filings (2)

ATXI Sets Virtual Annual Meeting to Elect Directors, Ratify Auditor — Dec 5, 2025 Risk: medium
Avenue Therapeutics, Inc. (ATXI) is holding its Annual Meeting of Stockholders virtually on December 30, 2025, at 10:00 a.m. Eastern Time. Stockholders will vot
Avenue Therapeutics, Inc. Announces Annual Meeting of Stockholders on June 24, 2024 — May 6, 2024 Risk: low
AVENUE THERAPEUTICS, INC. (ATXI) filed a Proxy Statement (DEF 14A) with the SEC on May 6, 2024. Annual Meeting of Stockholders to be held virtually on June 24,

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX